Overall Technical outlook

Price Summary

On 2026-04-30, APLLTD's stock started at 760.0, reached a high of 762.0, fell to 751.35, and ended -0.66% down at 755.0, with 27314 shares traded.
In the last 52 weeks, the stock's top price was 1039.1 and the bottom price was 646.55.
The projected price range for Alembic Pharmaceuticals Limited is between 720.0 and 1132.0, with an expected mean price of 939.9, according to 10 analysts.

Technicals

Support and Resistance: The price for APLLTD at 755.0 finds support at 698.3 and resistance at 783.2. This suggests a trading range, where 698.3 serves as a support level and 783.2 acts as a resistance point, potentially capping further gains.
APLLTD supportResistance e9711f
Support/Resistance for APLLTD


Aroon: The AROON is currently in a neutral position for Alembic Pharmaceuticals Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.
APLLTD aroon e9711f
Aroon chart for Alembic Pharmaceuticals Limited


Bol. Bands: The BOLL BANDS is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
APLLTD bbands e9711f
Bolinger Bands chart for Alembic Pharmaceuticals Limited


Parabolic SAR: The PSAR maintains a bullish outlook, reinforcing a support level that could help uphold the market's upward trend. This suggests that the market is likely to continue climbing, with the support providing a solid base for further gains.
APLLTD psar e9711f
Parabolic Stop and Reverse chart for Alembic Pharmaceuticals Limited


Stochastic: The current reading of the STOCHASTIC is neutral for APLLTD, with no clear signals for an upward or downward trend. This indicates that the market may be in a state of uncertainty, with no dominant force driving the direction.
APLLTD stoch e9711f
Stochastic chart for Alembic Pharmaceuticals Limited


Tripple Moving Agerage: The Tripple MOVING AVG is showing a neutral reading, with no clear direction indicated for upward or downward movement. This neutral position suggests a possible period of consolidation.
APLLTD trippleSMA e9711f
Tripple SMA chart for Alembic Pharmaceuticals Limited


A comprehensive approach to analyzing a company requires considering both its technical and fundamental aspects. The company's fundamentals, such as its earnings, growth prospects, and financial health, provide a strong foundation for understanding technical indicators. Additionally, examining the industry it operates in helps contextualize the company's position within the broader market. By integrating these factors, one can gain more valuable insights into the company's stock performance and potential investment opportunities.